An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to testify next week.

Full Article
An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to testify next week.

ChemImage, a Pittsburgh-based biotech firm, is suing Johnson & Johnson for allegedly breaching a multibillion-dollar contract related to AI imaging technology. The lawsuit stems from a partnership that aimed to enhance surgical robotics with ChemImage's innovative software, which provides real-time imaging for surgeons. As the trial begins, both companies are set to present their cases in federal court, with ChemImage seeking significant damages and the restoration of its intellectual property.

The case highlights the complexities of corporate partnerships in the tech industry, especially in the rapidly evolving field of AI. ChemImage claims that Johnson & Johnson's withdrawal from the agreement has severely impacted its operations and potential advancements in surgical outcomes. The outcome of this trial could set a precedent for future collaborations between biotech firms and large healthcare companies.

• ChemImage claims Johnson & Johnson breached a contract over AI imaging technology.

• The trial will determine the validity of contract termination and potential damages.

Key AI Terms Mentioned in this Article

AI Imaging Technology

AI imaging technology refers to software that enhances visual assessments during surgical procedures.

Surgical Robotics

Surgical robotics involves the use of robotic systems to assist in surgical procedures, improving precision and outcomes.

Contract Breach

Contract breach occurs when one party fails to fulfill its obligations under a legal agreement, impacting business operations.

Companies Mentioned in this Article

ChemImage

ChemImage specializes in AI-powered imaging solutions for surgical applications, aiming to improve surgical outcomes.

Johnson & Johnson

Johnson & Johnson is a global healthcare company involved in various sectors, including surgical robotics and medical devices.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 3month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 3month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 3month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 3month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics